Result of EGM
03 Agosto 2009 - 3:00AM
UK Regulatory
TIDMNIM
RNS Number : 7045W
Norwood Immunology Ld
03 August 2009
3 August 2009
Norwood Immunology Limited
Results of EGM
De-Listing, Equal Access Buy-Back and Streamlining of Operations
Norwood Immunology Limited ('Norwood Immunology' or 'the Group') (AIM:NIM), the
Group with technologies in the fields of the rejuvenation of the immune system
and stem cell therapies, today announces the results of its EGM, held on 31 July
2009.
All the resolutions proposed at the EGM were unanimously approved by those
shareholders casting a vote and, accordingly have been adopted.
The company received acceptances for its Equal Access Buy-Back Scheme for
42,115,879, an amount within the Buy-Back Limit (as defined in the Notice of
EGM) and accordingly the Company will be proceeding to purchase and then cancel
these shares.
The Board will also be implementing the streamlining proposals set out in the
EGM including the cancellation of the Company's admission to AIM to take
effect at 7.00 a.m. on 10 August 2009 (following the passing of the resolution
to de-list with 100% of votes cast in favour).
Enquiries:
+---------------------------------------+---------------------------------------+
| Norwood Immunology | +44 (0) 7860 295153 |
+---------------------------------------+---------------------------------------+
| Richard Williams, Chief Executive | |
| Officer | |
+---------------------------------------+---------------------------------------+
| | |
+---------------------------------------+---------------------------------------+
| KBC Peel Hunt Ltd (NOMAD & Broker) | +44 (0) 20 7418 8900 |
+---------------------------------------+---------------------------------------+
| Capel Irwin | |
+---------------------------------------+---------------------------------------+
| David Anderson | |
+---------------------------------------+---------------------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
REGUAAVRKNRBOAR
Norwood Immunology (LSE:NIM)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Norwood Immunology (LSE:NIM)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Norwood Imm. da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de Norwood Immunology